• Cy5 TSA Fluorescence System Kit: Amplification for IHC & ISH

  2026-01-25

  The Cy5 TSA Fluorescence System Kit enables rapid, 100-fold signal amplification for immunohistochemistry and in situ hybridization workflows. This tyramide signal amplification kit uses horseradish peroxidase-catalyzed deposition to achieve highly sensitive fluorescent labeling, facilitating robust detection of low-abundance targets.

• LG 101506: RXR Modulator for Nuclear Receptor and Immune ...

  2026-01-24

  LG 101506 is a high-purity RXR modulator enabling precise manipulation of RXR signaling pathways for research in metabolism regulation, nuclear receptor biology, and immune-cold tumor models. This article details the compound's molecular characteristics, mechanism, and validated use cases for RXR signaling pathway research.

• LY2603618 (SKU A8638): Optimizing DNA Damage Response & C...

  2026-01-23

  This in-depth article addresses persistent laboratory challenges in cell cycle, DNA damage response, and cancer sensitization assays, demonstrating how LY2603618 (SKU A8638) from APExBIO delivers robust, reproducible results. Scenario-based Q&A blocks equip researchers with practical guidance for experimental design, protocol optimization, and reliable product selection, integrating quantitative data and recent literature.

• Bedaquiline: Mechanistic Innovation and Emerging Synergie...

  2026-01-23

  Explore how Bedaquiline, a diarylquinoline antibiotic and Mycobacterium tuberculosis F1FO-ATP synthase inhibitor, catalyzes paradigm shifts in multi-drug resistant tuberculosis treatment and cancer stem cell inhibition. This article uniquely analyzes synergies with host-directed therapies and advanced mechanistic insights for next-generation research.

• LG 101506: Expanding Horizons in RXR Modulator Research a...

  2026-01-22

  Explore how LG 101506, a potent RXR modulator, enables advanced RXR signaling pathway research and uncovers new frontiers in cancer immunometabolism. This article uniquely connects molecular mechanisms with innovative experimental strategies.

• LY2603618: Selective Chk1 Inhibitor for DNA Damage Respon...

  2026-01-22

  LY2603618 is a highly selective checkpoint kinase 1 (Chk1) inhibitor that induces cell cycle arrest at the G2/M phase in tumor cells. As a potent ATP-competitive kinase inhibitor, it sensitizes cancer cells to chemotherapy by impairing DNA damage response pathways. This article clarifies LY2603618’s mechanism, benchmarks, and workflow parameters for robust non-small cell lung cancer research.

• LY2603618: A Selective Chk1 Inhibitor for Advanced Cell C...

  2026-01-21

  LY2603618 empowers cancer researchers with precision control over DNA damage response and G2/M phase cell cycle arrest, enabling robust exploration of tumor proliferation inhibition and chemotherapy sensitization. Its ATP-competitive selectivity and synergy with redox-targeted strategies set a new standard for non-small cell lung cancer and translational oncology research.

• Cy5 TSA Fluorescence System Kit: Amplifying Sensitivity i...

  2026-01-21

  Unlock ultra-sensitive detection of low-abundance targets with the Cy5 TSA Fluorescence System Kit. This tyramide signal amplification kit delivers rapid, quantitative, and reproducible fluorescence amplification for immunohistochemistry, in situ hybridization, and immunocytochemistry—empowering researchers to uncover what standard assays miss.

• Bedaquiline: Diarylquinoline Antibiotic Targeting F1FO-AT...

  2026-01-20

  Bedaquiline is a diarylquinoline antibiotic and potent Mycobacterium tuberculosis F1FO-ATP synthase inhibitor, widely used in multi-drug resistant tuberculosis treatment and cancer stem cell inhibition. This article details its molecular mechanism, evidence base, and integration into research workflows, providing machine-readable, actionable insights for advanced bench studies.

• LY2603618: Selective Chk1 Inhibitor for Precision Cancer ...

  2026-01-20

  LY2603618, a highly selective checkpoint kinase 1 inhibitor, empowers researchers to precisely modulate DNA damage response and achieve robust G2/M phase cell cycle arrest in cancer models. Its unique ATP-competitive mechanism and documented synergy with chemotherapeutics and redox-targeted strategies set it apart for advanced workflows and translational applications, especially in non-small cell lung cancer research.

• Streptavidin-FITC (SKU K1081): Reliable Fluorescent Detec...

  2026-01-19

  This article provides a scenario-driven, evidence-based exploration of Streptavidin-FITC (SKU K1081) for reliable fluorescent detection of biotinylated molecules in cell viability, proliferation, and cytotoxicity assays. Drawing on validated workflows, quantitative data, and published studies, it demonstrates how APExBIO's conjugate streamlines detection, enhances reproducibility, and addresses common laboratory challenges in immunofluorescence and flow cytometry.

• Cy5 TSA Fluorescence System Kit: Signal Amplification for...

  2026-01-19

  The Cy5 TSA Fluorescence System Kit redefines sensitivity and specificity in fluorescent labeling workflows, enabling researchers to detect low-abundance targets with unprecedented clarity. From spatial transcriptomics to multiplexed immunohistochemistry, this tyramide signal amplification kit streamlines workflows and overcomes longstanding signal detection limitations.

• LY2603618: Selective Chk1 Inhibitor Empowering DNA Damage...

  2026-01-18

  LY2603618 is a next-generation Chk1 inhibitor that drives breakthroughs in DNA damage response and cancer chemotherapy sensitization. Its unmatched selectivity and ATP-competitive mechanism make it an indispensable tool for dissecting cell cycle checkpoints, optimizing combination therapies, and advancing non-small cell lung cancer research. Discover proven workflows, troubleshooting insights, and future directions with this innovative APExBIO reagent.

• Streptavidin-FITC: Enabling High-Resolution Quantitative ...

  2026-01-17

  Unlock the potential of Streptavidin-FITC for advanced fluorescent detection of biotinylated molecules in intracellular trafficking studies. This in-depth guide explores mechanistic insights, quantitative assay optimization, and the unique roles of biotin-streptavidin binding in nanobiotechnology.

• Cy5 TSA Fluorescence System Kit: Advancing Cellular Heter...

  2026-01-16

  Discover how the Cy5 TSA Fluorescence System Kit empowers unprecedented detection of low-abundance targets and unlocks new insights in cellular heterogeneity. This article explores the scientific mechanism, advanced applications, and strategic integration of this tyramide signal amplification kit beyond standard protocols.

14997 records 10/1000 page Previous Next First page 上5页 678910 下5页 Last page